Dr. Y. Michael Shim, an esteemed physician-scientist who specializes in advanced pulmonary imaging and obstructive airway diseases, was named chief of the Division of Pulmonary and Critical Care Medicine effective April 1.
The division provides expert, comprehensive care for patients in the intensive care unit and for a range of pulmonary- and critical care-related conditions including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease and lung infections. The division also conducts cutting-edge research in those areas and others such as acute lung injury, pulmonary hypertension and sepsis.
In his new role, Dr. Shim will lead a team of skilled physicians and scientists focused on advancing the group’s clinical care, research and education missions, including working collaboratively to support the growing translational research portfolio and increasing hands-on educational training to teach future leaders in the field. He will also seek to expand access to comprehensive pulmonary and advanced lung disease care across Weill Cornell Medicine-affiliated NewYork-Presbyterian campuses, working closely with the lung transplant team at NewYork-Presbyterian. He succeeds Dr. Dana Zappetti and Dr. Kyu Rhee, who led the division in an interim capacity.
Dr. Shim spent more than two decades at the University of Virginia (UVA), where he most recently served as a professor of medicine and professor of radiology. He also held the John L. Guerrant Endowed Professorship.
“We are thrilled to welcome Dr. Shim as our new chief of pulmonary and critical care medicine,” said Dr. Myles Wolf, chair of the Weill Department of Medicine and physician-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center. “As an outstanding physician-scientist, Dr. Shim brings a vision for the division that builds on its strengths while expanding its impact in clinical programs, research and education. His leadership will position us at the forefront of emerging technologies and scientific advances that are reshaping the understanding and treatment of lung disease.” Read More